Transaction in own shares & TVR

RNS Number : 6942K
Transense Technologies PLC
09 May 2022
 

9 May 2022

 

Transense Technologies plc

("Transense", the "Group" or "the Company")

 

Transaction in own shares

Total voting rights

 

Transense Technologies plc (AIM: TRT), the developer of specialist sensor systems, announces that the Company has purchased 25,000 of its own ordinary shares of 10p each ("Ordinary Shares") at a price of 76 pence per share. These shares will be held in treasury for the time being to satisfy share option awards in the future.

Following this transaction, the total number of Ordinary Shares held as treasury shares by the Company is 115,000. The total number of Ordinary Shares in issue (including shares held as treasury shares) is 16,437,740. Therefore, the total number of voting rights in the Company is 16,322,740 which may  be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.  

In accordance with Article 5(1)(b) of the UK version of Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, the information below contains information about the purchases made by Shard Capital Stockbrokers on behalf of the Company as part of the buyback programme.

 

 

Aggregate information:

Shares purchased:

Transense Technologies plc (ISIN CODE: GB00BDHDTH21)

Date of purchases:

6 May 2022

Investment firm

Shard Capital Stockbrokers

Venue

London Stock Exchange

Number of ordinary shares purchased

25,000

Volume-weighted average price, pence

76

Highest price paid (per ordinary share), pence

76

Lowest price paid (per ordinary share), pence

76

 

 

For further information please visit www.transense.com or contact:

Transense Technologies plc

Nigel Rogers (Executive Chairman)

Melvyn Segal (CFO)

Via Walbrook PR

Allenby Capital (Nominated Adviser and Broker)

Jeremy Porter / George Payne (Corporate Finance)

Tony Quirke (Sales and Corporate Broking)

Tel: +44 (0)20 3328 5656

Walbrook PR

Tom Cooper/Nick Rome/Nicholas Johnson

Tel: +44 (0)20 7933 8780

Transense@walbrookpr.com


Notes to Editors:

 

Transense develops and supplies wireless sensor technology and systems. The Company has three business areas:

· SAW , patent protected Surface Acoustic Wave sensor technology that provides real time measurement of torque, temperature, pressure and strain, that is used to improve efficiency, performance and safety of propulsion systems and machinery;

· Translogik , smart, connected commercial vehicle tyre inspection equipment, used by vehicle fleets to more easily gather and maintain accurate tyre safety and condition data; and

· iTrack , a tyre pressure monitoring system for off-highway machinery, licensed exclusively to Bridgestone Corporation, the world's largest tyre producer, under a ten-year deal.

Target market sectors include automotive, aerospace and industrial machinery. The Group's strategy is to leverage excellence in innovation, know-how in wireless sensor technologies and form industry partnerships in these global growth sectors to maximise shareholder value through sustained revenue growth from all three principal technologies - SAW, iTrack and Translogik.

Transense is headquartered in Oxfordshire, UK, and was admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: TRT), in 1999.

For further information please contact transense@walbrookpr.com

 


Schedule of Purchases - Individual Transactions

 

Number of Shares

Price Per Share (pence)

Trading Venue

Date of Transaction

Time of transaction

25,000

76

London Stock Exchange

6 May 2022

15:25:11

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSEAASPEELAEFA
UK 100

Latest directors dealings